Skip to main content
. 2017 Sep 13;125(9):097010. doi: 10.1289/EHP849

Table 4.

Preintervention to postintervention mean changes (95% CI) for treatments relative to placebo, adjusted for age, gender and indoor particulate matter (n=114 participants).

Outcome Adjusted for age, gender, PM2.5a Adjusted for age, gender, PMcb Adjusted for age, gender, PM2.5, PMcb
Woodstove changeout Air filter Woodstove changeout Air filter Woodstove changeout Air filter
PAQLQ            
 Overall 0.18 (0.34, 0.71) 0.15 (0.58, 0.27) 0.20 (0.36, 0.77) 0.13 (0.57, 0.32) 0.20 (0.36, 0.77) 0.21 (0.67, 0.24)
 Symptoms 0.38 (0.20, 0.96) 0.13 (0.60, 0.34) 0.39 (0.23, 1.0) 0.11 (0.60, 0.37) 0.38 (0.23, 1.0) 0.20 (0.70, 0.29)
 Limitation of Activity 0.13 (0.50, 0.75) 0.27 (0.78, 0.24) 0.16 (0.52, 0.83) 0.29 (0.82, 0.24) 0.16 (0.52, 0.83) 0.31 (0.85, 0.24)
 Emotion 0.10 (0.63, 0.44) 0.14 (0.57, 0.30) 0.06 (0.64, 0.51) 0.08 (0.53, 0.38) 0.06 (0.64, 0.51) 0.19 (0.66, 0.27)
Two-week spirometry monitoring            
 Evening FEV1 % predicted 2.6 (7.8, 13) 0.73 (9.1, 7.7) 1.3 (10, 13) 0.51 (9.3, 8.3) 1.2 (10, 13) 1.3 (10, 7.8)
 Morning FEV1 % predicted 3.2 (7.4, 14) 1.7 (10, 6.9) 2.2 (9.2, 14) 2.1 (8.4, 4.2) 2.2 (9.3, 14) 2.4 (11, 6.7)
 Evening PEF % predicted 6.9 (2.7, 17) 0.62 (7.4, 8.6) 6.3 (4.0, 16) 2.2 (5.9, 10) 6.2 (4.1, 17) 1.2 (7.2, 9.7)
 Morning PEF % predicted 7.7 (2.0, 17) 1.7 (6.3, 9.7) 7.1 (3.1, 17) 2.5 (5.6, 11) 7.0 (3.2, 17) 1.8 (6.6, 10)
 Diurnal PEF variability, % 2.7 (7.4, 2.0) 3.6 (7.6, 0.4) 3.0 (8.2, 2.3) 3.2 (7.4, 1.0) 3.0 (8.3, 2.3) 2.7 (7.0, 1.7)

Note: FEV1 forces expiratory volume in first second; PAQLQ, Pediatric Asthma Quality of Life Questionnaire; PEF, peak expiratory flow.

a

Missing observations for models with PM2.5: n=5 for PAQLQ measures; n=41 for spirometry measures.

b

Missing observations for models with PMc: n=6 for PAQLQ measures; n=38 for spirometry measures.